These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17659717)

  • 1. Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin.
    Shibata Y; Baba E; Ariyama H; Miki R; Ogami N; Arita S; Qin B; Kusaba H; Mitsugi K; Noshiro H; Yao T; Nakano S
    World J Gastroenterol; 2007 Jul; 13(26):3634-7. PubMed ID: 17659717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basaloid-squamous carcinoma of the esophagus treated by preoperative chemotherapy: report of two cases.
    Koide N; Kishimoto K; Nakamura T; Igarashi J; Maezawa T; Hanazaki K; Adachi W; Amano J
    Surg Today; 2003; 33(6):444-7. PubMed ID: 12768371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Matsumura S; Iwahashi M; Yamaue H
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26725778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
    Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
    Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
    Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
    Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
    Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of neuroendocrine cell carcinoma of the esophagus with lung metastases successfully treated with CPT-11/CDDP].
    Takeoka T; Hirao M; Fujitani K; Yamamoto K; Asaoka T; Ikenaga M; Miyamoto A; Ikeda M; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2121-3. PubMed ID: 24394033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of an advanced esophageal carcinoma treated by neoadjuvant chemotherapy (CDDP + 5-FU) and evaluation of effect on metastatic lymph nodes].
    Minamide J; Koizumi H; Ozawa Y; Fukano F; Tokunaga M; Moriwaki R; Tamai S; Kameda Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1849-52. PubMed ID: 8379678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M; Iwahashi M; Nakamura M; Yamaue H
    J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus.
    Yamasaki M; Miyata H; Tanaka K; Shiraishi O; Motoori M; Peng YF; Yasuda T; Yano M; Shiozaki H; Mori M; Doki Y
    Oncology; 2011; 80(5-6):307-13. PubMed ID: 21778771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy.
    Shigemitsu K; Naomoto Y; Shirakawa Y; Haisa M; Gunduz M; Tanaka N
    Jpn J Clin Oncol; 2002 Aug; 32(8):310-4. PubMed ID: 12411570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of docetaxel/cisplatin/fluorouracil combination chemotherapy against metastatic esophageal squamous cell carcinoma.
    Takahashi H; Arimura Y; Yamashita K; Okahara S; Tanuma T; Kodaira J; Hokari K; Tsukagoshi H; Shinomura Y; Hosokawa M
    J Thorac Oncol; 2010 Jan; 5(1):122-8. PubMed ID: 19898259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
    Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy for basaloid squamous carcinoma of the esophagus.
    Tsuchiya Y; Onda M; Miyashita M; Hagiwara N; Maruyama H; Matsutani T; Okawa K; Takubo K; Yamashita K; Sasajima K
    Hepatogastroenterology; 1999; 46(29):2868-71. PubMed ID: 10576363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of primary esophageal carcinoma treated with 5-fluorouracil plus cisplatin and curatively resected after complete response].
    Iwasaki K; Ogata T; Fujikawa H; Shirai J; Cho H; Yoshikawa T; Ohta Y; Tachibana S; Oosaka Y; Tsuchida A
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2146-8. PubMed ID: 24394041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.